The Korea Research Institute of Standards and Science has successfully developed a nanomaterial capable of simultaneously ...

As brain tumors grow, they must do one of two things: push against the brain or use finger-like extensions to invade and ...

Trained on multi-hospital data, iSeg spots moving tumors doctors sometimes miss, edging radiation treatment toward pinpoint ...

A new study details the development of a nanoparticle-based system that delivers concentrated chemotherapy specifically to ...

In radiation therapy, precision can save lives. Oncologists must carefully map the size and location of a tumor before ...

Early imaging and specialist evaluation are crucial when treatment ... stabbing facial pain often mistaken for sinus headache or pressure. Nasopharyngeal cancer slowly blocking sinus drainage: Growing ...

A novel immuno-PET/CT imaging technique has identified and validated a potent biomarker for nasopharyngeal cancer (NPC). The biomarker, CD70, is highly and constantly expressed in NPCs, and CD70 ...

Penpulimab-kcqx, a humanized immunoglobulin G1 monoclonal antibody, blocks the interaction between the programmed death 1 receptor on T-cells and programmed death ligand 1 and 2 on tumor cells.

This randomised, single-centre, double-blind, placebo-controlled, phase 2 trial was conducted at Sun Yat-sen University Cancer Centre in Guangzhou, China. Adult patients (aged 18–65 years) with newly ...

The adjuvant therapy camrelizumab increased the 3-year event-free survival (EFS) rate vs standard of care from 77.3% to 86.9%, translating to a 44% reduced risk of death or relapse in patients with ...